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Ligand-gated ion channels (LGICs) belongs to ionotropic receptors or channel- 
linked receptors. They are a group of transmembrane ion channels that are opened or 
closed in response to the binding of a chemical messenger ,such as the endogenous 
neurotransmitter. Ligand-gated ion channels (LGICs) is associated with many 
seriously nervous system diseases, and it can be the drug target of nervous system 
diseases. However, the defects on the knowledge of the structure and function of the 
LGICs have been the key obstacle to hinder the development of nervous system 
diseases treatment. 
We take the neuronal nicotinic acetylcholine receptors (nAChR) α7 subtype, the 
drug target of many neurological diseases as a point of entry, and we are particular 
interested in the structure of neuronal nicotinic acetylcholine receptors (nAChR) α7 
subtype. Using combinational methods of molecular biology, cell biology, structural 
biology and other disciplines, we focuse on resolving its three-dimensional crystal 
structure and the ligand binding complex structure, clarifying its ligand binding and 
gating mechanism, and providing the structure and theoretical basis for drug 
development. 
Using a unique, efficient mammalian cell expression system which developed by 
ourselves, we get a neuronal nicotinic acetylcholine receptor (nAChR) α7 subtype 
cDNA, whose expression level reached mg level in vitro. Then we get the high purity 
pentamer form full-length neuronal acetylcholine receptor (nAChR) α7 subtype 
protein, achieving a breakthrough in the expression and purification of protein nAChR 
α7 subtype, laying a good foundation for getting crystal structure. Meanwhile, we use 
the conventional sitting drop method as well as the latest developed Biclle-Lipid 
method to try to screen the protein crystal growth conditions, which are greatly 
helpful for getting the high resolution three-dimensional structure of the protein 
neuronal nicotinic acetylcholine receptors (nAChR) α7 subtype. And we get some 
crystal may be the crystal of the full-length neuronal nicotinic acetylcholine receptors 

















heterologous expression systems to express and purify the intracellular domian( ICD) 
of neuronal acetylcholine receptor ( nAChR) α7 subtype, we get the stable pentamer 
form of nAChR α7 ICD. These works may guide the research on the gating 
mechanism of nerve acetylcholine receptor (nAChR) α7 subtype.   
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1.1.1 膜蛋白功能的结构基础研究具有重大的理论和实践意义  





















1.1.2 膜蛋白结构与功能的国内外研究现状和发展趋势  
与膜蛋白功能的重要性相比，我们对其功能的结构基础的了解甚为贫乏。迄
今为止，蛋白质数据库（Protein Data Bank）收录了生物大分子的结构近 8万个，























图 1 现有药物作用靶点统计（Nat Rev Drug Discov 2006, 5: 993-996） 
Fig. 1 Statistics of current drug targets 
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